In the DVT group, the expression levels of EDA-A2, FGF-6, Dkk-4, IL-1 F9, Galectin-3, Layilin, bIG-H3, CHI3L1, ULBP-2, Gas-1, IGFBG-5, and FGF-9 were upregulated, consistent with the initial screening results. The gene discussed is LGALS3; the disease is deep vein thrombosis.